Status:
COMPLETED
Clinical Audit of GI Endoscopic Complications in a Tertiary Care Hospital
Lead Sponsor:
Asian Institute of Gastroenterology, India
Conditions:
Endoscopy
Complication
Eligibility:
All Genders
Brief Summary
Endoscopy of the upper gastrointestinal tract using fiberoptic endoscopes was introduced in the late 1950s and provided the first opportunity for direct visualization of the esophagus, stomach, and du...
Detailed Description
1\. STUDY OBJECTIVES 1a. Primary objective - Clinical audit of complications in gastrointestinal endoscopy unit from a tertiary care centre. 1b. Secondary objective - NA 2\. STUDY POPULATION- Conse...
Eligibility Criteria
Inclusion
- All patients who undergo any diagnostic or therapeutic endoscopic procedure during the period and develop any complication including:
- Diagnostic and therapeutic upper gastrointestinal endoscopy,
- Diagnostic and therapeutic colonoscopy,
- Endoscopic retrograde cholangiopancreatography (ERCP),
- Endoscopic Ultrasound (EUS),
- Peroral Endoscopic Myotomy (POEM),
- Enteroscopy (Antegrade, Retrograde or spiral)
- Endoscopic mucosal resection (EMR),
- Endoscopic Submucosal Resection (ESD),
- Submucosal Tunnel Endoscopic Resection (STER)
- Anti- Reflex Mucosal Ablation (ARMA)
- Anti- Reflex Mucosal Resection (ARMS)
- GERD-X
- Endoscopic Sleeve Gastrectomy (ESG)
- Intra-gastric Balloon insertion
Exclusion
- Those who are not willing to give the consent.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
42471 Patients enrolled
Trial Details
Trial ID
NCT05228353
Start Date
June 1 2021
End Date
January 31 2022
Last Update
September 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AIG Hospitals
Hyderabad, Telangana, India, 500032